Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.

O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, Dittmer DP.

Blood. 2009 Jun 4;113(23):5938-41. doi: 10.1182/blood-2008-09-179168. Epub 2009 Feb 27.

2.

Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.

Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R.

PLoS One. 2015 May 5;10(5):e0126439. doi: 10.1371/journal.pone.0126439. eCollection 2015.

3.

Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.

Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R.

PLoS Pathog. 2012;8(8):e1002884. doi: 10.1371/journal.ppat.1002884. Epub 2012 Aug 23. Erratum in: PLoS Pathog. 2013 Mar;9(3). doi: 10.1371/annotation/bb6f7450-8506-41c3-8519-020df8b382b9.

4.

Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.

O'Hara AJ, Chugh P, Wang L, Netto EM, Luz E, Harrington WJ, Dezube BJ, Damania B, Dittmer DP.

PLoS Pathog. 2009 Apr;5(4):e1000389. doi: 10.1371/journal.ppat.1000389. Epub 2009 Apr 17.

5.

The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility.

Wu YH, Hu TF, Chen YC, Tsai YN, Tsai YH, Cheng CC, Wang HW.

Blood. 2011 Sep 8;118(10):2896-905. doi: 10.1182/blood-2011-01-330589. Epub 2011 Jun 28.

6.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
7.

KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

Lambe JS, Oble DA, Nandula SV, Sevilla DW, Colovai AI, Mansukhani M, Chari A, Murty VV, Alobeid B, Bhagat G.

Hematol Oncol. 2009 Dec;27(4):203-10. doi: 10.1002/hon.892.

PMID:
19337983
8.

Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.

Marshall V, Parks T, Bagni R, Wang CD, Samols MA, Hu J, Wyvil KM, Aleman K, Little RF, Yarchoan R, Renne R, Whitby D.

J Infect Dis. 2007 Mar 1;195(5):645-59. Epub 2007 Jan 23.

PMID:
17262705
9.

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, McCrae KR, Fakhari FD, Dittmer DP, Renne R.

J Virol. 2006 May;80(10):4833-46.

10.

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.

Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR.

Cell Host Microbe. 2011 Nov 17;10(5):515-26. doi: 10.1016/j.chom.2011.09.012.

11.

Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.

McAllister SC, Moses AV.

Curr Top Microbiol Immunol. 2007;312:211-44. Review.

PMID:
17089799
12.

Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.

Ramalingam D, Happel C, Ziegelbauer JM.

J Virol. 2015 Apr;89(8):4249-61. doi: 10.1128/JVI.03687-14. Epub 2015 Jan 28.

13.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
14.

The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.

Wies E, Hahn AS, Schmidt K, Viebahn C, Rohland N, Lux A, Schellhorn T, Holzer A, Jung JU, Neipel F.

J Biol Chem. 2009 Mar 27;284(13):8525-38. doi: 10.1074/jbc.M809252200. Epub 2009 Jan 7.

15.

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.

Roy D, Sin SH, Damania B, Dittmer DP.

Blood. 2011 Aug 18;118(7):e32-9. doi: 10.1182/blood-2010-12-323659. Epub 2011 Jun 17.

16.

Identification of cellular genes targeted by KSHV-encoded microRNAs.

Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R.

PLoS Pathog. 2007 May 11;3(5):e65.

17.

CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA.

Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF.

J Infect Dis. 2012 Apr 1;205(7):1095-9. doi: 10.1093/infdis/jis032. Epub 2012 Feb 22.

18.

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

Schulz TF, Cesarman E.

Curr Opin Virol. 2015 Oct;14:116-28. doi: 10.1016/j.coviro.2015.08.016. Epub 2015 Sep 29. Review.

PMID:
26431609
19.

Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.

Rimessi P, Bonaccorsi A, St├╝rzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P.

J Virol. 2001 Aug;75(15):7161-74.

20.

Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature.

Xiao J, Selvaggi SM, Leith CP, Fitzgerald SA, Stewart J 3rd.

Cancer Cytopathol. 2013 Nov;121(11):661-9. doi: 10.1002/cncy.21311. Epub 2013 Jun 13. Review.

Supplemental Content

Support Center